Heparin-induced thrombocytopenia secondary prevention: Difference between revisions
Gerald Chi- (talk | contribs) (Created page with "__NOTOC__ {{Heparin-induced thrombocytopenia}} {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}, Aric C. Hall, M.D., [mailto:achall@bidmc.harvard.edu] ==Overview== ==Second...") |
Shyam Patel (talk | contribs) No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Heparin-induced thrombocytopenia}} | {{Heparin-induced thrombocytopenia}} | ||
{{CMG}}; | {{CMG}}; {{shyam}} | ||
==Overview== | ==Overview== | ||
There are no secondary prevention measures for HIT. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no secondary prevention measures for HIT. | |||
==Reference== | |||
{{Reflist|2}} | |||
[[Category:Hematology]] | |||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 01:36, 31 July 2017
|
Heparin-induced thrombocytopenia |
|
Differentiating Heparin-induced thrombocytopenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Heparin-induced thrombocytopenia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia secondary prevention |
|
FDA on Heparin-induced thrombocytopenia secondary prevention |
|
CDC on Heparin-induced thrombocytopenia secondary prevention |
|
Heparin-induced thrombocytopenia secondary prevention in the news |
|
Blogs on Heparin-induced thrombocytopenia secondary prevention |
|
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
|
Risk calculators and risk factors for Heparin-induced thrombocytopenia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]
Overview
There are no secondary prevention measures for HIT.
Secondary Prevention
There are no secondary prevention measures for HIT.